A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

M Gentile¹, T D Shanafelt², G Cutrona³, S Molica⁴, G Tripepi⁵, I Alvarez⁶, F R Mauro⁷, N Di Renzo⁸, F Di Raimondo⁹, I Vincelli¹⁰, K Todoerti¹¹, S Matis¹², C Musolino¹³, S Fabris¹⁴, E Vigna¹, L Levato⁴, S Zupo³, F Angrilli¹⁵, U Consoli¹⁶, G Festini¹⁷, G Longo¹⁸, A Cortelezzi¹⁴, A Arcari¹⁹, M Federico²⁰, D Mannina²¹, A G Recchia²², A Neri¹⁴, N E Kay², M Ferrarini¹², F Morabito^{1

22}

Affiliations

¹ Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.
² Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
³ Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica, SS Molecular Diagnostics IRCCS S. Martino-IST, Genova, Italy.
⁴ Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
⁵ Consiglio Nazionale delle Ricerche, Istituto di Fisiologia Clinica, Reggio Calabria, Italy.
⁶ Division of Haematology, Dipartimento Oncologico e Tecnologie Avanzate, Arcispedale S. Maria Nuova/IRCCS, Reggio Emilia, Italy.
⁷ Divisione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy.
⁸ Hematology Unit, Ospedale Vito Fazzi, Lecce, Italy.
⁹ Division of Haematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania, Italy.
¹⁰ Hematology Unit, Dipartimento di Onco-Ematologia, A.O. of Reggio Calabria, Reggio Calabria, Italy.
¹¹ Laboratory of Preclinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Dipartimento Onco-Ematologico, Potenza, Italy.
¹² Direzione Scientifica IRCCS, San Martino IST, Genova, Italy.
¹³ Division of Haematology, Dipartimento di Medicina Interna,University of Messina, Messina, Italy.
¹⁴ Department of Clinical Sciences and Community Health, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
¹⁵ Department of Hematology, Ospedale Santo Spirito, Pescara, Italy.
¹⁶ U.O.S. di Emato-Oncologia, Ospedale Garibaldi-Nesima, Catania, Italy.
¹⁷ Dipartimento ad Attività Integrata Oncologia, Centro di Riferimento Ematologico-Seconda Medicina, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Trieste, Italy.
¹⁸ Dipartimento di Oncologia, Unità di Ematologia, Ospedale San Vincenzo, Taormina, Italy.
¹⁹ Dipartimento di Oncologia ed Ematologia, Hematology Unit, Department of Onco-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
²⁰ Department of Onco-hematology, Università di Modena Centro Oncologico Modenese, Policlinico Modena, Italy.
²¹ Divisione di Ematologia, Ospedale Papardo, Messina, Italy.
²² Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano, Cosenza, Italy.

PMID: 26648537
DOI: 10.1038/leu.2015.333

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

M Gentile et al. Leukemia. 2016 Jun.

. 2016 Jun;30(6):1440-3.

doi: 10.1038/leu.2015.333. Epub 2015 Dec 9.

Authors

Affiliations

¹ Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.
² Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
³ Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica, SS Molecular Diagnostics IRCCS S. Martino-IST, Genova, Italy.
⁴ Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
⁵ Consiglio Nazionale delle Ricerche, Istituto di Fisiologia Clinica, Reggio Calabria, Italy.
⁶ Division of Haematology, Dipartimento Oncologico e Tecnologie Avanzate, Arcispedale S. Maria Nuova/IRCCS, Reggio Emilia, Italy.
⁷ Divisione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy.
⁸ Hematology Unit, Ospedale Vito Fazzi, Lecce, Italy.
⁹ Division of Haematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania, Italy.
¹⁰ Hematology Unit, Dipartimento di Onco-Ematologia, A.O. of Reggio Calabria, Reggio Calabria, Italy.
¹¹ Laboratory of Preclinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Dipartimento Onco-Ematologico, Potenza, Italy.
¹² Direzione Scientifica IRCCS, San Martino IST, Genova, Italy.
¹³ Division of Haematology, Dipartimento di Medicina Interna,University of Messina, Messina, Italy.
¹⁴ Department of Clinical Sciences and Community Health, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
¹⁵ Department of Hematology, Ospedale Santo Spirito, Pescara, Italy.
¹⁶ U.O.S. di Emato-Oncologia, Ospedale Garibaldi-Nesima, Catania, Italy.
¹⁷ Dipartimento ad Attività Integrata Oncologia, Centro di Riferimento Ematologico-Seconda Medicina, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Trieste, Italy.
¹⁸ Dipartimento di Oncologia, Unità di Ematologia, Ospedale San Vincenzo, Taormina, Italy.
¹⁹ Dipartimento di Oncologia ed Ematologia, Hematology Unit, Department of Onco-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
²⁰ Department of Onco-hematology, Università di Modena Centro Oncologico Modenese, Policlinico Modena, Italy.
²¹ Divisione di Ematologia, Ospedale Papardo, Messina, Italy.
²² Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano, Cosenza, Italy.

PMID: 26648537
DOI: 10.1038/leu.2015.333

No abstract available

PubMed Disclaimer

References

1. Blood. 2007 Jun 1;109(11):4679-85 - PubMed
1. Br J Haematol. 2008 Mar;140(5):537-46 - PubMed
1. Am J Hematol. 2014 Jul;89(7):743-50 - PubMed
1. Blood. 2008 Jun 15;111(12):5446-56 - PubMed
1. Blood. 2013 Feb 21;121(8):1403-12 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

Affiliations

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

Authors

Affiliations

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources